Balancing wellness and waste: sustainable solutions for medical packaging: MHolland
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
CN201 is a next generation CD3xCD19 bispecific antibody that augments and diversifies Merck’s pipeline, with potential applications in B-cell malignancies and autoimmune diseases
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Subscribe To Our Newsletter & Stay Updated